wechat public accounts

Address: Building F2, No. 88, Kechuang 6th Street, Beijing Economic Development Zone

Tel: +86  010-56315466

Fax: +86  010-56315314

E-mail: hr@jacobiopharma.com

             bd@jacobiopharma.com

 

 

百度地图API自定义地图

Copyright: Jacobio Pharmaceuticals Co., Ltd.   Beijing ICP preparation 17065868-1   

 

Steve Zhou/Senior VP of R&D

 

  • Novartis-NIBR
  • University of Melbourne Ph.D., UCSD postdoc

Yinxiang Wang/CEO &Chairman

 

  • Founder & Former CEO & CSO, Betta Pharma
  • Former General Manager, Amgen Betta Pharma
  • Univ. of Arkans, Ph.D., Yale postdoc.

Shaojing Hu/President of R&D

 

  • Former Chief Chemist, Betta Pharma
  • Institute for Diabetes Discovery, Neurogen
  • Simon Fraser Univ. Ph.D., Yale postdoc.

 

 
 

Xiaojie Wang/President of Administration

 

  • Former Administrative VP, Betta Pharma
  • Peking University EMBA
 
 
 

Yunyan Hu/Senior VP of R&D

 

 

  • Former Associate Director, R&D center of Betta
  • Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, M. S
  • Lanzhou University, B. Sc
 
 
 
 
 
 
 

Wayne Long/VP R&D

 

  • Former Assistant Director, R&D center of Betta
  • Beijing University of Technology, Ph.D.
  • Health Science Center at Beijing University, Postdoc
 
 

Qiao Li/Vice President Biostatistics and Data Science

 

  • Head of Biostatistics and Programming, Astellas (China)
  • Head of Biostatisitcs, Novo Nordisk (China)
  • Imperial College London, Post-doc
  • University of East Anglia, Ph.D.

 

Yang Xie/VP R&D

 

  • Forma Therapeutics
  • Novartis Presidential Postdoc Fellow
  • Yale University, Ph.D.
 
 

Tian Zhu/VP BD

 

  • Former Assistant Director, Early Drug R&D Department, Betta
  • University of Illinois at Chicago, Ph.D.
 

Yanping Wang/Pharmacology VP

 

  • Former Assistant Director, Early Drug R&D Department, Betta
  • University of Illinois at Chicago, Ph.D.
 
 

Yuli Ding/VP of Clinical Development

 

  • Head of Clinical R&D in Sihuan Pharmacential Ltd, etc.
  • Immunology TA head in J&J and worked as GTM in J&J Netherland and Belgium office
  • Pharmacology M.S. in Inner-Mongolia Medical University.
 

Andrea Wang-Gillam/CMO and Senior Vice President

 

  • Director of Developmental Therapeutics (Phase I) Program at Washington University in St. Louis
  • Clinical Director of Gastrointestinal Oncology Program at Washington University in St. Louis 
  • Associate Professor in the Division of Oncology at Washington University in St. Louis
  • Medicine Residency and Hematology/Oncology Fellowship at University of Arkansas School of Medicine 
  • Internal Medicine Residency at Cleveland Clinic
  • University of Arkansas School of Medicine MD, PhD
 
 

Hong Zhuang/Senior Vice President of CMC

 

  • Bachelor and Master degrees in science from Peking University
  • Ph.D. degree in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah
  • Senior Director of Drug Product Development and Manufacturing in Turning Point Therapeutics
  • Senior Research Scientist/Principal Research Scientist in Eli Lilly and Company